{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:31:03Z","timestamp":1755801063404,"version":"3.44.0"},"reference-count":26,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>M\u00e9ni\u00e8re\u2019s disease (MD) is a disorder of the inner ear characterised by sudden vertigo attacks, unilateral sensorineural hearing loss, tinnitus, and aural fullness. The evidence supporting the diagnostic and treatment options is limited. The diagnosis should be based on criteria put forth by The B\u00e1r\u00e1ny Society. This review finds that the assessment of MD should rely on anamnesis and audiometry and can be supported by caloric testing, video head impulse test, and MRI. The limited evidence on available treatment options emphasises the critical role of social interventions in mitigating the psychosocial burden on patients.<\/jats:p>","DOI":"10.61409\/v07240462","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T08:07:09Z","timestamp":1749542829000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["M\u00e9ni\u00e8re\u2019s disease"],"prefix":"10.61409","author":[{"given":"Hicham","family":"Laghmoch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper","family":"Gr\u00f8nlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Devantier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarki Ditlev","family":"Djurhuus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,6,2]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Lopez-Escamez JA, Carey J, Chung WH et al. Diagnostic criteria for Meni\u00e9re's disease. J Vestib Res. 2015;25(1):1-7. https:\/\/doi.org\/10.3233\/VES-150549","DOI":"10.3233\/VES-150549"},{"key":"ref1","unstructured":"H\u00f8reforeningens Men\u00e9reudvalg 2022. Meni\u00e8reramtes erfaringer og vilk\u00e5r i dagligdagen 2020-2021, 2022. https:\/\/hoereforeningen.dk\/media\/436270\/meni%C3%A8reramtes-erfaringer-og-vilkaar-i-dagligdagen-hoereforeningen-2020-2021.pdf (04. jul 2024)"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Lopez-Escamez JA et al. Epidemiology and genetics of Meniere's disease. Curr Opin Neurol. 2023;37(1):88-94. https:\/\/doi.org\/10.1097\/WCO.0000000000001227","DOI":"10.1097\/WCO.0000000000001227"},{"key":"ref3","unstructured":"Holmelund M, Bojer D. Meni\u00e8res sygdom, 2023. https:\/\/www.sundhed.dk\/borger\/patienthaandbogen\/oere-naese-hals\/sygdomme\/indre-oere-og-balanceorganer\/meni-res-sygdom\/ (04. jul 2024)"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Gates P. Hypothesis: could Meniere's disease be a channelopathy? Intern Med J. 2005;35(8):488-9. https:\/\/doi.org\/10.1111\/j.1445-5994.2005.00891.x","DOI":"10.1111\/j.1445-5994.2005.00891.x"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Hoskin JL. Meniere's disease: new guidelines, subtypes, imaging, and more. Curr Opin Neurol. 2022;35(1):90-97. https:\/\/doi.org\/10.1097\/WCO.0000000000001021","DOI":"10.1097\/WCO.0000000000001021"},{"key":"ref6","unstructured":"Gr\u00f8nlund C, Isenberg AL, Lindelof M, Djurhuus BD. HINTS til diagnostik af akut svimle patienter. Ugeskrift L\u00e6ger. 2019;181:V04190251. https:\/\/ugeskriftet.dk\/videnskab\/hints-til-diagnostik-af-akut-svimle-patienter"},{"key":"ref7","unstructured":"Gr\u00f8nlund C, Lembeck MA, Devantier L et al. Den episodisk svimle patient. Ugeskrift L\u00e6ger. 2021;183:V10200757. https:\/\/ugeskriftet.dk\/videnskab\/den-episodisk-svimle-patient"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Oliveira LNR, Oliveira CLA, Lopes KC, Gananca FF. Diagnostic assessment of patients with Meniere's disease through caloric testing and the video-head-impulse test. Braz J Otorhinolaryngol. 2021;87(4):428-433. https:\/\/doi.org\/10.1016\/j.bjorl.2019.10.008","DOI":"10.1016\/j.bjorl.2019.10.008"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Tamanini JB, Mezzalira R, Vallim MGB et al. Dissociation between video head impulse test and caloric test: a marker of meniere's disease? - a systematic review and meta-analysis. Braz J Otorhinolaryngol. 2023;89(4):101279. https:\/\/doi.org\/10.1016\/j.bjorl.2023.101279","DOI":"10.1016\/j.bjorl.2023.101279"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Rosengren SM, Young AS, Taylor RL, Welgampola MS. Vestibular function testing in the 21st century: video head impulse test, vestibular evoked myogenic potential, video nystagmography; which tests will provide answers? Curr Opin Neurol. 2022;35(1):64-74. https:\/\/doi.org\/10.1097\/WCO.0000000000001023","DOI":"10.1097\/WCO.0000000000001023"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Van Esch BF, van der Zaag-Loonen H, Bruintjes T et al. Interventions for Meniere's disease: an umbrella systematic review. BMJ Evid Based Med. 2022;27(4):235-245. https:\/\/doi.org\/10.1136\/bmjebm-2020-111410","DOI":"10.1136\/bmjebm-2020-111410"},{"key":"ref12","unstructured":"Devantier L, Henriksen JJM. Menie\u0300res sygdom (morbus Menie\u0300re), 2022. https:\/\/dsohh.dk\/wp-content\/uploads\/2022\/05\/Meniere.pdf (04. jul 2024)"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Kitahara T, Okamoto H, Fukushima M et al. A two-year randomized trial of interventions to decrease stress hormone vasopressin production in patients with Meniere's disease - a pilot study. PLoS One. 2016;11(6):e0158309. https:\/\/doi.org\/10.1371\/journal.pone.0158309","DOI":"10.1371\/journal.pone.0158309"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Webster KE, George B, Lee A et al. Lifestyle and dietary interventions for Meniere's disease. Cochrane Database Syst Rev. 2023;2(2):CD015244. https:\/\/doi.org\/10.1002\/14651858.CD015244.pub2","DOI":"10.1002\/14651858.CD015244.pub2"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Rezaeian A, Abtahi H, Moradi M, Farajzadegan Z. The effect of vestibular rehabilitation in Meniere's disease: a systematic review and meta-analysis of clinical trials. Eur Arch Otorhinolaryngol. 2023;280(9):3967-3975. https:\/\/doi.org\/10.1007\/s00405-023-08066-x","DOI":"10.1007\/s00405-023-08066-x"},{"key":"ref16","unstructured":"House of Hearing. House of hearing, 2024. https:\/\/houseofhearing.dk (04. jul 2024)"},{"key":"ref17","unstructured":"Retsinformation. Vejledning om helbredskrav til k\u00f8rekort, 2022. https:\/\/www.retsinformation.dk\/eli\/retsinfo\/2022\/10150 (04. jul 2024)"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Lee A, Webster KE, George B et al. Surgical interventions for Meniere's disease. Cochrane Database Syst Rev. 2023;2(2):CD015249. https:\/\/doi.org\/10.1002\/14651858.CD015249.pub2","DOI":"10.1002\/14651858.CD015249.pub2"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Webster KE, Galbraith K, Harrington-Benton NA et al. Systemic pharmacological interventions for M\u00e9ni\u00e8re's disease. Cochrane Database Syst Rev. 2023;2(2):CD015171. https:\/\/doi.org\/10.1002\/14651858.CD015171.pub2","DOI":"10.1002\/14651858.CD015171.pub2"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Adrion C, Fischer CS, Wagner J et al. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016;352:h6816. https:\/\/doi.org\/10.1136\/bmj.h6816","DOI":"10.1136\/bmj.h6816"},{"key":"ref21","unstructured":"Sundhedsstyrelsen. Behandling af meni\u00e8res, 2018. https:\/\/www.sst.dk\/da\/udgivelser\/2018\/~\/media\/70EF9497B3E94310B2419EDB7BB3AB1A.ashx (04. jul 2024)"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Webster KE, Lee A, Galbraith K et al. Intratympanic corticosteroids for M\u00e9ni\u00e8re's disease. Cochrane Database Syst Rev. 2023;2(2):CD015245. https:\/\/doi.org\/10.1002\/14651858.CD015245.pub2","DOI":"10.1002\/14651858.CD015245.pub2"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Webster KE, Galbraith K, Lee A et al. Intratympanic gentamicin for M\u00e9ni\u00e8re's disease. Cochrane Database Syst Rev. 2023;2(2):CD015246. https:\/\/doi.org\/10.1002\/14651858.CD015246.pub2","DOI":"10.1002\/14651858.CD015246.pub2"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Webster KE, George B, Galbraith K et al. Positive pressure therapy for M\u00e9ni\u00e8re's disease. Cochrane Database Syst Rev. 2023;2(2):CD015248. https:\/\/doi.org\/10.1002\/14651858.CD015248.pub2","DOI":"10.1002\/14651858.CD015248.pub2"},{"key":"ref25","unstructured":"Seneste"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:27:58Z","timestamp":1755696478000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V07240462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,2]]},"references-count":26,"URL":"https:\/\/doi.org\/10.61409\/v07240462","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2025,6,2]]}}}